000 03133cam a2200349 a 4500
003 EG-GiCUC
005 20250223032457.0
008 191210s2019 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.08.09.Ph.D.2019.Be.P
100 0 _aBerween Mahmoud Abdelelgawad Elmahmoudy
245 1 4 _aThe possible protective effects of DDP4 (dipeptidylpeptidase-4) inhibitors and pyrrolidine dithiocarbamate in thioacetamide-induced ulcerative colitis in rats /
_cBerween Mahmoud Abdelelgawad Elmahmoudy ; Supervised Mohamed Farrag Elyamany , Laila Ahmed Rashed , Mai Ahmed Galal
246 1 5 _aالدور الوقائى الممكن لمثبطات دايى بيبتيدال وبيروليدين داى ثايو كربامات فى تقرح القالون المستحدث بالثيواسيتاميد بالجرذان
260 _aCairo :
_bBerween Mahmoud Abdelelgawad Elmahmoudy ,
_c2019
300 _a191 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
520 _aBackground: Ulcerative colitis (UC) is a disease related to a combination of genetic and environmental factors, associated with overproduction of both ROS and RNSleading to oxidative and nitrosative stress, as well as release of pro-inflammatory cytokines. Methods: The effect of sulfasalzine, pyrrolidine dithiocarbamate (PDTC) and saxagliptin was evaluated in thioacetamide (TAA)-induced UC model in the current study.Animals were treated orally with vehicle, sulfasalazine (500 mg/kg), PDTC (100 mg/kg), and saxagliptin (10 mg/kg) for two weeks,UC was induced by single intrarectal instillation of TAA at day eight. Colon samples were collected to assess colonic content of phosphorylated extraregular signal translated kinases (PERK), mitogen-activated protein kinase (MAPK), cAMP response element-binding protein (CREB), Interleukin (IL)-12, Caspase-3, Ý-defensin, glucagon like peptide (GLP)-1,inducible nitric oxide synthase (iNOS), as well as to perform histopathological investigations. Results:TAA-treated rats experienced increases in colon mass index, ulcerative area, colonic PERK, MAPK, CREB, caspase-3, IL-12,Ý-defensin, iNOS, together with decreases in body weight, colon mass index, ulcerative area and GLP-1 and distortion of colonic architecture, as shown by histopathological examination. PDTC and saxagliptin attenuated the severity of colitis, as demonstrated by decrease in body weight loss, colon mass index, ulcerative area as well as decrease in colonic PERK, MAPK, CREB, caspase-3, IL-12,Ý-defensin and iNOS
530 _aIssued also as CD
653 4 _aInflammatory mediators
653 4 _aOxidative stress
653 4 _aUlcerative colitis
700 0 _aLaila Ahmed Rashed ,
_eSupervisor
700 0 _aMai Ahmed Galal ,
_eSupervisor
700 0 _aMohamed Farrag Elyamany ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c75794
_d75794